论文部分内容阅读
目的探讨乳腺钼靶在筛查早期乳腺癌患者的临床价值。方法选取2013年1月至2014年1月医院早期乳腺癌患者100例,采用乳腺钼靶X线扫描检查,观察乳腺钼靶在筛查早期乳腺癌方面的灵敏度、特异性、漏诊率、误诊率以及准确度。结果经过筛查,乳腺钼靶在筛查早期乳腺癌中,灵敏度为90.0%,特异性为67.0%,漏诊率为10.0%,误诊率为33.0%,准确度为77.0%。结论乳腺钼靶在筛查乳腺癌方面灵敏度、特异性以及准确度都非常高,因此具有较高的临床价值,但对于早期乳腺癌的诊断而言存在一定的局限性,即较乳腺癌诊断来说特异性、灵敏度、准确率都会有所下降,误诊率、漏诊率有所上升。
Objective To investigate the clinical value of mammography in the screening of early breast cancer patients. Methods 100 patients with early breast cancer in our hospital from January 2013 to January 2014 were selected. The mammography was used to evaluate the sensitivity, specificity, missed diagnosis rate and misdiagnosis rate of breast mammography in the screening of early breast cancer And accuracy. Results After screening, the breast molybdenum target screening for early breast cancer, the sensitivity was 90.0%, specificity was 67.0%, missed diagnosis rate was 10.0%, the misdiagnosis rate was 33.0%, the accuracy was 77.0%. Conclusion Breast molybdenum targets in the screening of breast cancer sensitivity, specificity and accuracy are very high, so has a high clinical value, but there are some limitations for the diagnosis of early breast cancer, breast cancer than the diagnosis That specificity, sensitivity, accuracy will decline, misdiagnosis rate, missed diagnosis rate increased.